Table 2.
Comparison of baseline feature in groups with and without sleep disorders
| Mean±SD | ||||
| Sleep disorders (n=15) | Without sleep disorders (n=9) | |||
| n | n | |||
| Age | 15 | 64.4±.8.0 | 9 | 67.8±4.7 |
| Physiological indicators | ||||
| BMI | 15 | 26.3±6.2 | 9 | 23.7±2.3 |
| SBP (mm Hg) | 12 | 140.0±10.4 | 8 | 136.0±19.0 |
| DBP (mm Hg) | 12 | 78.4±14.0 | 8 | 71.9±6.5 |
| eGFR (mL/min/1.73 m2) | 15 | 64.5±22.5 | 9 | 67.6±9.3 |
| Triglyceride (mg/dL） | 14 | 191.6±121.7 | 9 | 148.3±88.7 |
| non-HDL-c (mg/dL） | 14 | 146.9±41.1 | 9 | 126±19.6 |
| HbA1c (%) | 15 | 8.0±1.0 | 9 | 8.0±1.4 |
| QOL | ||||
| EuroQOL-5D-5L (score) | 15 | 0.83±0.12 | 9 | 0.90±0.09 |
| Subjective health status (%) | 15 | 69.9±17.2 | 9 | 83.9±12.4 |
| Number of steps per day | 11 | 6819.7±2399 | 9 | 8915.3±3022.5 |
| Quality of sleep | ||||
| ISI (score) | 15 | 8.4±3.8 | 9 | 3.1±2.2 |
| PSQI (score) | 15 | 6.2±2.2 | 9 | 2.7±1.9 |
| JESS (score) | 15 | 5.2±3.5 | 8 | 3.8±2.2 |
BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, haemoglobin A1c; HDL-c, high-density lipoprotein-cholesterol; ISI, Insomnia Severity Index; JESS, Japanese version of Epworth Sleepiness Scale; PSQI, Pittsburgh Sleep Quality Index; QOL, quality of life; SBP, systolic blood pressure.